Note: Ingredients listed on restricted chemical lists
EC/CAS
918-481-9/64742-48-9
Name of the chemical
Naphtha (petroleum), hydrotreated heavy
Concentration
≥95
General Information
Version
0.2
Revision date
2022-11-30
Product name
TIMPEST ANTITARLO
1.2.2. Uses advised against
Uses other than those indicated above
Icons in SDS
Company Information
company name
MAZZONI MARIO EREDI
e-mail address of the competent person responsible for the Safety Data Sheet
info@timpest.com
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H304, H400, H410
Hazard statements
Code
Statements
H304
May be fatal if swallowed and enters airways
Section 2
SECTION 2: Hazards identification
Adverse physicochemical, human health and environmental effects
May be fatal if swallowed and enters airways. Very toxic to aquatic life with long lasting effects.
2.2 Label elements
Labelling
Hazard pictograms
GHS08 GHS09
Signal word
Danger
Contains
Hydrocarbons, C10-C13, n-alkanes, isoalkanes, cyclics, < 2% aromatics; Permethrin_MAZZONI
Hazard statements
H304 - May be fatal if swallowed and enters airways. H410 - Very toxic to aquatic life with long lasting effects.
Precautionary statements
P273 - Avoid release to the environment. P301+P310 - IF SWALLOWED: Immediately call a POISON CENTER or doctor. P331 - Do NOT induce vomiting. P391 - Collect spillage. P405 - Store locked up. P501 - Dispose of contents/container to hazardous or special waste collection point, in accordance with local, regional, national and/or international regulation.
Supplemental label elements
EUH208 - Contains Permethrin_MAZZONI(52645-53-1). May produce an allergic reaction.
2.3 Other hazards
The components of the mixture do not meet the identification criteria for PBT or vPvB substances, in accordance with Annex XIII of the REACH Regulation. Contains no PBT/vPvB substances ≥ 0.1% assessed in accordance with REACH Annex XIII The mixture does not contain substance(s) included in the list established in accordance with Article 59(1) of REACH for having endocrine disrupting properties, or is not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at a concentration equal to or greater than 0,1 %
